Expertise in
16
conditions

Shintaro Hirata

Hiroshima, JP 
Expertise in
16
conditions
Hiroshima, JP 

Overview

Shintaro Hirata practices practicing medicine in Hiroshima, Japan.

Mr. Hirata is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Rheumatoid Arthritis (RA), Arthritis, Granulomatosis with Polyangiitis, Microscopic Polyangiitis, and Endoscopy.

He is actively involved in clinical research, co-authoring 177 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Hiroshima, Japan
Other Locations
Minami, 7348551, Japan
Course Of Advanced Clinical Research Of Cancer, Tokyo, Japan
Chuo, Japan
Chuo, Japan
Kyoto, Japan
Kitakyushu, Japan
Fukuoka, Japan
Chuo, Japan
Japan
Matsuyama, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
A 52-week, Phase 3, Multicentre, Randomised, Double Blind, Efficacy and Safety Study, Comparing GSK3196165 With Placebo and With Tofacitinib in Combination With Conventional Synthetic DMARDs, in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic DMARDs or Biologic DMARDs
Enrollment Status: Terminated
Publish Date: November 30, 2023
Intervention Type: Drug, Biological
Study Drugs: Otilimab, Tofacitinib, csDMARDs
Study Phase: Phase 3
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
A Phase 3, Double-Blind, Multicenter Study to Evaluate the Long-Term Safety and Efficacy of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
Enrollment Status: Terminated
Publish Date: May 16, 2023
Intervention Type: Drug
Study Drug: Baricitinib
Study Phase: Phase 3
View 1 Less Clinical Trial

177 Total Publications

Longitudinal Evaluation of Serum Varicella-zoster Virus Viral Load in a Woman with Systemic Lupus Erythematosus Complicated by a Visceral Disseminated Varicella-zoster Virus Infection: A Case Report.
Longitudinal Evaluation of Serum Varicella-zoster Virus Viral Load in a Woman with Systemic Lupus Erythematosus Complicated by a Visceral Disseminated Varicella-zoster Virus Infection: A Case Report.
Journal: Internal medicine (Tokyo, Japan)
Published: August 19, 2026

Frequently Asked Questions about Shintaro Hirata

Is Shintaro Hirata a top-rated expert for Rheumatoid Arthritis (RA)?

MediFind is an objective health platform that identifies experts based on real-world data. Shintaro Hirata is classified as an Elite expert for Rheumatoid Arthritis (RA), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shintaro Hirata participate in research or clinical trials?

Yes. Shintaro Hirata has published 177 articles and abstracts on conditions like Rheumatoid Arthritis (RA). You can view a list of Shintaro Hirata's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Hirata's expertise for a condition
ConditionClose
View All 12 Advanced Conditions
View All 33 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile